Lexology November 17, 2022
McGuireWoods LLP

The Vistria Group and GHO Capital Partners will acquire a controlling interest in Alcami Corp. from Madison Dearborn Partners (MDP) and Ampersand Capital Partners, according to a news release.

Alcami, based in Wilmington, N.C., is a contract development, testing and manufacturing organization for pharma and biotech companies. Founded in 1979, the company provides solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring and pharmaceutical support services.

The Vistria Group, based in Chicago, focuses on making investments in middle market companies in healthcare and a few other industries. Founded in 2013, the firm pursues control and minority equity investments...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Is AI’s next big leap understanding emotion? $50M for Hume says yes

Share This Article